403 related articles for article (PubMed ID: 26728390)
1. Chronic Metabolic Acidosis Activates Renal Tubular Sodium Chloride Cotransporter through Angiotension II-dependent WNK4-SPAK Phosphorylation Pathway.
Fang YW; Yang SS; Cheng CJ; Tseng MH; Hsu HM; Lin SH
Sci Rep; 2016 Jan; 6():18360. PubMed ID: 26728390
[TBL] [Abstract][Full Text] [Related]
2. Activation of the renal Na+:Cl- cotransporter by angiotensin II is a WNK4-dependent process.
Castañeda-Bueno M; Cervantes-Pérez LG; Vázquez N; Uribe N; Kantesaria S; Morla L; Bobadilla NA; Doucet A; Alessi DR; Gamba G
Proc Natl Acad Sci U S A; 2012 May; 109(20):7929-34. PubMed ID: 22550170
[TBL] [Abstract][Full Text] [Related]
3. Aldosterone does not require angiotensin II to activate NCC through a WNK4-SPAK-dependent pathway.
van der Lubbe N; Lim CH; Meima ME; van Veghel R; Rosenbaek LL; Mutig K; Danser AH; Fenton RA; Zietse R; Hoorn EJ
Pflugers Arch; 2012 Jun; 463(6):853-63. PubMed ID: 22549242
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II signaling increases activity of the renal Na-Cl cotransporter through a WNK4-SPAK-dependent pathway.
San-Cristobal P; Pacheco-Alvarez D; Richardson C; Ring AM; Vazquez N; Rafiqi FH; Chari D; Kahle KT; Leng Q; Bobadilla NA; Hebert SC; Alessi DR; Lifton RP; Gamba G
Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4384-9. PubMed ID: 19240212
[TBL] [Abstract][Full Text] [Related]
5. Acute insulin stimulation induces phosphorylation of the Na-Cl cotransporter in cultured distal mpkDCT cells and mouse kidney.
Sohara E; Rai T; Yang SS; Ohta A; Naito S; Chiga M; Nomura N; Lin SH; Vandewalle A; Ohta E; Sasaki S; Uchida S
PLoS One; 2011; 6(8):e24277. PubMed ID: 21909387
[TBL] [Abstract][Full Text] [Related]
6. Aldosterone modulates thiazide-sensitive sodium chloride cotransporter abundance via DUSP6-mediated ERK1/2 signaling pathway.
Feng X; Zhang Y; Shao N; Wang Y; Zhuang Z; Wu P; Lee MJ; Liu Y; Wang X; Zhuang J; Delpire E; Gu D; Cai H
Am J Physiol Renal Physiol; 2015 May; 308(10):F1119-27. PubMed ID: 25761881
[TBL] [Abstract][Full Text] [Related]
7. SPAK deficiency corrects pseudohypoaldosteronism II caused by WNK4 mutation.
Chu PY; Cheng CJ; Wu YC; Fang YW; Chau T; Uchida S; Sasaki S; Yang SS; Lin SH
PLoS One; 2013; 8(9):e72969. PubMed ID: 24039833
[TBL] [Abstract][Full Text] [Related]
8. Modulation of NCC activity by low and high K(+) intake: insights into the signaling pathways involved.
Castañeda-Bueno M; Cervantes-Perez LG; Rojas-Vega L; Arroyo-Garza I; Vázquez N; Moreno E; Gamba G
Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1507-19. PubMed ID: 24761002
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of angiotensin II stimulation of NCC are time-dependent in mDCT15 cells.
Ko B; Mistry A; Hanson L; Mallick R; Hoover RS
Am J Physiol Renal Physiol; 2015 Apr; 308(7):F720-7. PubMed ID: 25651566
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of sodium-chloride cotransporter modulation by angiotensin II.
Castañeda-Bueno M; Gamba G
Curr Opin Nephrol Hypertens; 2012 Sep; 21(5):516-22. PubMed ID: 22820370
[TBL] [Abstract][Full Text] [Related]
11. WNK4 is the major WNK positively regulating NCC in the mouse kidney.
Takahashi D; Mori T; Nomura N; Khan MZ; Araki Y; Zeniya M; Sohara E; Rai T; Sasaki S; Uchida S
Biosci Rep; 2014 May; 34(3):. PubMed ID: 24655003
[TBL] [Abstract][Full Text] [Related]
12. Renal Natriuretic Peptide Receptor-C Deficiency Attenuates NaCl Cotransporter Activity in Angiotensin II-Induced Hypertension.
Shao S; Li XD; Lu YY; Li SJ; Chen XH; Zhou HD; He S; Guo YT; Lu X; Gao PJ; Wang JG
Hypertension; 2021 Mar; 77(3):868-881. PubMed ID: 33486984
[TBL] [Abstract][Full Text] [Related]
13. Arginine vasopressin regulates the renal Na
Carbajal-Contreras H; Murillo-de-Ozores AR; Magaña-Avila G; Marquez-Salinas A; Bourqui L; Tellez-Sutterlin M; Bahena-Lopez JP; Cortes-Arroyo E; Behn-Eschenburg SG; Lopez-Saavedra A; Vazquez N; Ellison DH; Loffing J; Gamba G; Castañeda-Bueno M
Am J Physiol Renal Physiol; 2024 Feb; 326(2):F285-F299. PubMed ID: 38096266
[TBL] [Abstract][Full Text] [Related]
14. WNK-SPAK-NCC cascade revisited: WNK1 stimulates the activity of the Na-Cl cotransporter via SPAK, an effect antagonized by WNK4.
Chávez-Canales M; Zhang C; Soukaseum C; Moreno E; Pacheco-Alvarez D; Vidal-Petiot E; Castañeda-Bueno M; Vázquez N; Rojas-Vega L; Meermeier NP; Rogers S; Jeunemaitre X; Yang CL; Ellison DH; Gamba G; Hadchouel J
Hypertension; 2014 Nov; 64(5):1047-53. PubMed ID: 25113964
[TBL] [Abstract][Full Text] [Related]
15. Glucose/Fructose Delivery to the Distal Nephron Activates the Sodium-Chloride Cotransporter via the Calcium-Sensing Receptor.
Bahena-Lopez JP; Rojas-Vega L; Chávez-Canales M; Bazua-Valenti S; Bautista-Pérez R; Lee JH; Madero M; Vazquez-Manjarrez N; Alquisiras-Burgos I; Hernandez-Cruz A; Castañeda-Bueno M; Ellison DH; Gamba G
J Am Soc Nephrol; 2023 Jan; 34(1):55-72. PubMed ID: 36288902
[TBL] [Abstract][Full Text] [Related]
16. Dietary salt regulates the phosphorylation of OSR1/SPAK kinases and the sodium chloride cotransporter through aldosterone.
Chiga M; Rai T; Yang SS; Ohta A; Takizawa T; Sasaki S; Uchida S
Kidney Int; 2008 Dec; 74(11):1403-9. PubMed ID: 18800028
[TBL] [Abstract][Full Text] [Related]
17. WNK bodies cluster WNK4 and SPAK/OSR1 to promote NCC activation in hypokalemia.
Thomson MN; Cuevas CA; Bewarder TM; Dittmayer C; Miller LN; Si J; Cornelius RJ; Su XT; Yang CL; McCormick JA; Hadchouel J; Ellison DH; Bachmann S; Mutig K
Am J Physiol Renal Physiol; 2020 Jan; 318(1):F216-F228. PubMed ID: 31736353
[TBL] [Abstract][Full Text] [Related]
18. SPAK and OSR1 play essential roles in potassium homeostasis through actions on the distal convoluted tubule.
Ferdaus MZ; Barber KW; López-Cayuqueo KI; Terker AS; Argaiz ER; Gassaway BM; Chambrey R; Gamba G; Rinehart J; McCormick JA
J Physiol; 2016 Sep; 594(17):4945-66. PubMed ID: 27068441
[TBL] [Abstract][Full Text] [Related]
19. Constitutively Active SPAK Causes Hyperkalemia by Activating NCC and Remodeling Distal Tubules.
Grimm PR; Coleman R; Delpire E; Welling PA
J Am Soc Nephrol; 2017 Sep; 28(9):2597-2606. PubMed ID: 28442491
[TBL] [Abstract][Full Text] [Related]
20. Disruption of the with no lysine kinase-STE20-proline alanine-rich kinase pathway reduces the hypertension induced by angiotensin II.
Cervantes-Perez LG; Castaneda-Bueno M; Jimenez JV; Vazquez N; Rojas-Vega L; Alessi DR; Bobadilla NA; Gamba G
J Hypertens; 2018 Feb; 36(2):361-367. PubMed ID: 28877076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
